SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-11-006775
Filing Date
2011-04-21
Accepted
2011-04-21 18:18:34
Documents
1
Period of Report
2011-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3923
  Complete submission text file 0001179110-11-006775.txt   5250
Mailing Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 919 313-4760
TRANZYME INC (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4819 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address
Thomas Helmut (Reporting) CIK: 0001515616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 11774384